Rainey & Randall Investment Management Inc. Q4 2022 vs. Q1 2023: A Comprehensive 13F Holdings Comparison

Rainey & Randall Investment Management Inc. recently released their 13F statements for Q4 2022 and Q1 2023, revealing some interesting changes in holdings. In this blog post, we'll take a closer look at the data to analyze the shifts in share count and value across various companies. From popular tech firms to ETFs, bank stocks, and healthcare REITs, let's dive into the breakdown.

Starting with one of the most significant changes, Rainey & Randall pulled out of holding First Trust International IPO ETF (FPXI) in Q1 2023 and sold their entire 5,733 share count for a total value of $233,000. On the other hand, they invested in Meta Platforms Inc (META) and bought 2,877 shares worth $609,000 - a staggering 76.1% increase in value over the previous quarter.

Another remarkable shift in their portfolio was the increase in shares of Schwab Strategic Trust ETFs. Rainey & Randall raised their stock count of Schwab Strategic Trust U.S. Large Cap ETF (SCHG), Schwab Strategic Trust U.S. Small Cap ETF (SCHA), and Schwab Strategic Trust U.S. Large Cap Growth ETF (SCHG) by 6.7%, 10.5%, and 22.1%, respectively, from the previous quarter. The company also showed interest in investing in Invesco QQQ Trust (QQQ) and Apple Inc (AAPL), buying 33.1% and 27.1% more shares in the Q1 2023 quarter compared to Q4 2022.

However, Rainey & Randall also sold off a few stocks that had been performing well. For instance, they withdrew their holdings from BNY Mellon Core Bond ETF (BKLN) and realized a 100% decrease in stock share count, netting them $0 in Q1 2023. Similarly, they abandoned their Investment in iShares Nasdaq Biotechnology ETF (IBB) completely. The company had 1563 shares in this ETF in Q4, with a value of $205 thousand. However, in Q1 2023, they have no shares at all.

In finance, diversification is key, and Rainey & Randall clearly follow this policy. To this end, they successfully increased their share count in Vanguard Bond Index Funds (BND) by 6.6%, iShares U.S. Small-Cap ETF (IJR) by 2.5%, and iShares Russell 2,000 Growth ETF (IWO) by 14.4%, adding to the value of their portfolio significantly. Nevertheless, they also downsized their holdings in some stocks, such as Medical Properties Trust, Inc. (MPW) and iShares U.S. Healthcare ETF (IYH), with decreases of 37.4% and 4.2%, respectively, compared to the previous quarter.

Finally, Rainey & Randall made an entrance into some companies in Q1 2023, buying new shares worth thousands of dollars in electric vehicle innovator Tesla, Inc. (TSLA) and e-commerce giant Amazon.com, Inc. (AMZN). They also bought $204 thousand worth of Chipotle Mexican Grill, Inc. (CMG) shares for the first time, indicating their interest in the food industry.

In conclusion, Rainey & Randall's 13F statements for Q4 2022 and Q1 2023 reflect an interesting mix of buying, selling, and holding. Their portfolio's diversification and focus on sectors such as technology, healthcare, and real estate suggest a strategic investment approach. However, only time will tell how successful this strategy turns out to be in the long run.